Modifying HIV Proteins To Kill Latently Infected Cells
Steven R. King of the University of Michigan in the U.S. proposes to engineer HIV proteins that can target and destroy HIV in latently infected cells. If successful, these new anti-viral drugs together with conventional treatments could completely clear the virus from people, resulting in a cure for HIV infection.